ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Ing Japan Fund 13

Ing Japan Fund 13 (GSJPF)

23.77
0.00
(0.00%)
Cerrado 22 Enero 10:30AM
Gráfico avanzado

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
23.77
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
401
23.77 Rango del Día 23.77
20.77 Rango de 52 semanas 24.80
Precio Anterior
23.77
Precio de Apertura
23.77
Última hora de negociación
Volumen promedio (3 m)
1,279
Volumen financiero
-
Precio Promedio Ponderado
-

GSJPF Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.311.3213981244723.4623.8123.4673623.71231104DE
40.130.54991539763123.6424.1323.46107623.84915728DE
120.813.5278745644622.9624.822.52127923.65687087DE
260.692.9896013864823.0824.820.77117323.16785156DE
522.6212.387706855821.1524.820.77116322.82676796DE
1564.3122.14799588919.4624.818.73127521.39545604DE
2604.3122.14799588919.4624.818.73127521.39545604DE

GSJPF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ing Japan Fund 13?
El precio actual de las acciones de Ing Japan Fund 13 es 23.77 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ing Japan Fund 13?
Ing Japan Fund 13 ha negociado en un rango de 20.77 € a 24.80 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALMASMastrad
0.0218 €
(122.45%)
24.21M
MLAATAzorean Tech
0.16 €
(60.00%)
1.05k
CDUConduril Engenharia SA
24.60 €
(30.16%)
150
ALNMRNamR SA
0.1745 €
(29.74%)
46.73k
ALSPWSpineway
0.129 €
(28.87%)
960.57k
HYPDSHipay Group DS
0.0002 €
(-98.18%)
115.57k
MLWEYWeya
0.015 €
(-42.31%)
30.9k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
7.54k
DRVDSDrone Volt DS
0.0007 €
(-22.22%)
143.64k
POXELPoxel
0.31 €
(-20.61%)
2.9M
ATOAtos SE
0.0022 €
(0.00%)
301.81M
BCPBanco Comercial Portugues SA
0.5132 €
(0.16%)
35.61M
ALMASMastrad
0.0218 €
(122.45%)
24.21M
ALVERVergnet
0.0014 €
(0.00%)
17.57M
ALCYBCybergun
0.0001 €
(0.00%)
15.68M
Hardazoak Hardazoak 2 minutos hace
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 2 minutos hace
KPIFF
wadegarret wadegarret 3 minutos hace
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 3 minutos hace
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 4 minutos hace
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 5 minutos hace
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 5 minutos hace
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 6 minutos hace
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 6 minutos hace
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 8 minutos hace
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 8 minutos hace
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 9 minutos hace
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 10 minutos hace
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 11 minutos hace
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 11 minutos hace
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 14 minutos hace
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 14 minutos hace
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 14 minutos hace
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 15 minutos hace
Whats 305
RNVA
theorysuit theorysuit 17 minutos hace
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 17 minutos hace
Yes I bet it 2x better then before strap in stock-nuts
CLHI

Su Consulta Reciente

Delayed Upgrade Clock